Holen Sie sich die Stockscreener-App
2.13
0.47%
0.010
Schlusskurs vom Vortag:
$2.12
Offen:
$2.08
24-Stunden-Volumen:
57,001
Relative Volume:
0.04
Marktkapitalisierung:
$4.52M
Einnahmen:
$35.49M
Nettoeinkommen (Verlust:
$-6.04M
KGV:
-0.1636
EPS:
-13.0191
Netto-Cashflow:
$-6.42M
1W Leistung:
-10.13%
1M Leistung:
-58.24%
6M Leistung:
-84.40%
1J Leistung:
-85.56%
1-Tages-Spanne:
$2.06
$2.165
1-Wochen-Bereich:
$2.06
$2.4499
52-Wochen-Spanne:
$2.01
$24.30
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Firmenname
Sunshine Biopharma Inc
Sektor
Telefon
954-330-0684
Adresse
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
2.13 | 4.52M | 35.49M | -6.04M | -6.42M | -13.02 |
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
Sunshine Biopharma Inc Aktie (SBFM) Neueste Nachrichten
Sunshine Biopharma Inc (SBFM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sunshine Biopharma Inc (SBFM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sunshine Biopharma Inc (SBFMW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sunshine Biopharma Inc (SBFMW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sunshine Biopharma Inc (SBFMW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sunshine Biopharma Inc (SBFM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sunshine Biopharma Inc (SBFM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sunshine Biopharma Inc (SBFM) Institutional Confidence - TradingKey
Sunshine Biopharma Inc (SBFM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sunshine Biopharma Inc (SBFM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sunshine Biopharma Inc (SBFM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sunshine Biopharma Inc (SBFM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sunshine Biopharma Inc (SBFMW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sunshine Biopharma Inc (SBFMW) Institutional Confidence - TradingKey
Sunshine Biopharma Inc (SBFMW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sunshine Biopharma Inc (SBFMW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sunshine Biopharma Inc (SBFMW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SBFM SEC FilingsSunshine Biopharma Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Sunshine Biopharma (SBFM) Holds Near Support After Marginal Gains Amid Biotech Sector VolatilityVirgin POC - newsline.com
Sunshine Biopharma (SBFM) Slips 6% as Stock Tests Key Support at $2.11RVOL Spike - newsline.com
Sunshine Biopharma Company Profile & Introduction - Moomoo
Sunshine Biopharma (SBFM) Shows Modest Gains, Holds Above Key SupportDelta Hedging - newsline.com
$Sunshine Biopharma (SBFM.US)$ - Moomoo
Sunshine Biopharma Inc Stock Short Interest Rises to 68.28% - Quiver Quantitative
Sunshine Biopharma (NASDAQ: SBFM) approves Series C warrant provisions after reverse split - Stock Titan
Sunshine Biopharma (SBFM) Slips 2.44% as Stock Holds Above Key SupportPut Flow Alert - newsline.com
Sunshine Biopharma Inc. (SBFM) Q1 2026 Earnings: Pre‑Revenue Biotech Reports Net Loss, Stock Declines - newsline.com
😭😭😭 - Moomoo
$Sunshine Biopharma (SBFM.US)$ :( - Moomoo
SBFM Stock Jumps As Sunshine Biopharma Secures New Drug Approvals - StocksToTrade
Sunshine Biopharma (SBFM) Gains Approval for Generic Rivaroxaban in Canada - GuruFocus
Sunshine Biopharma announces Canadian approval for Rivaroxaban - TipRanks
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R) - guardonline.com
Generic Xarelto pill from Sunshine Biopharma wins Canada approval - Stock Titan
Why Sunshine Biopharma (SBFM) stock dropped after hours today - MSN
Sunshine Biopharma Stock Quote, Share Price, News and Analysis - Longbridge
SBFM Q1 2026 Earnings: Reported Loss of -$0.25 Per Share as Clinical Pipeline AdvancesEarnings Call Transcript - newsline.com
Sunshine Biopharma (SBFM) Secures Patent for Coronavirus Treatme - GuruFocus
Sunshine Biopharma Approves Dilutive Share and Warrant Actions - TipRanks
Sunshine Biopharma (SBFM) approves warrant provisions after May 19 offering - Stock Titan
Major holder of Sunshine Biopharma (NASDAQ: SBFM) approves share and Series C warrant terms - Stock Titan
Sunshine Biopharma receives patent for coronavirus treatment compounds By Investing.com - Investing.com South Africa
Sunshine Biopharma receives patent for coronavirus treatment compounds - Investing.com
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology - New Castle News
New coronavirus patent aims to keep treatments working as virus mutates - Stock Titan
Sunshine Biopharma stock tumbles after reverse split announcement - Investing.com
Sunshine Biopharma drops 5.17% after announcing a one-for-ten reverse stock split. - Pluang
Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today - Benzinga
Sunshine Biopharma announces 1-for-10 reverse stock split - Investing.com UK
Sunshine Biopharma Announces 1-for-25 Reverse Stock Split Effective May 29, 2026 - geneonline.com
Sunshine Biopharma (SBFM) Implements Reverse Stock Split for Nas - GuruFocus
Finanzdaten der Sunshine Biopharma Inc-Aktie (SBFM)
Umsatz
Nettogewinn
Free Cashflow
ENV
11.23%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):